ProPhase Labs Inc (PRPH)
4.15
-0.12
(-2.81%)
USD |
NASDAQ |
Jun 28, 16:00
4.14
-0.01
(-0.24%)
After-Hours: 20:00
ProPhase Labs Accounts Receivable (Quarterly): 35.12M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 35.12M |
December 31, 2023 | 40.18M |
September 30, 2023 | 38.64M |
June 30, 2023 | 38.57M |
March 31, 2023 | 37.84M |
December 31, 2022 | 37.57M |
September 30, 2022 | 38.23M |
June 30, 2022 | 35.79M |
March 31, 2022 | 24.73M |
December 31, 2021 | 18.52M |
September 30, 2021 | 10.68M |
June 30, 2021 | 6.644M |
March 31, 2021 | 14.34M |
December 31, 2020 | 1.975M |
September 30, 2020 | 2.999M |
June 30, 2020 | 1.93M |
March 31, 2020 | 1.213M |
December 31, 2019 | 2.01M |
September 30, 2019 | 1.483M |
June 30, 2019 | 0.738M |
March 31, 2019 | 0.788M |
December 31, 2018 | 2.968M |
September 30, 2018 | 1.051M |
June 30, 2018 | 1.363M |
March 31, 2018 | 1.785M |
Date | Value |
---|---|
December 31, 2017 | 1.945M |
September 30, 2017 | 1.113M |
June 30, 2017 | 1.835M |
March 31, 2017 | 3.41M |
December 31, 2016 | 5.77M |
September 30, 2016 | 3.833M |
June 30, 2016 | 1.801M |
March 31, 2016 | 2.688M |
December 31, 2015 | 4.00M |
September 30, 2015 | 2.766M |
June 30, 2015 | 1.245M |
March 31, 2015 | 3.468M |
December 31, 2014 | 5.836M |
September 30, 2014 | 4.051M |
June 30, 2014 | 2.343M |
March 31, 2014 | 2.856M |
December 31, 2013 | 5.319M |
September 30, 2013 | 4.445M |
June 30, 2013 | 1.128M |
March 31, 2013 | 3.08M |
December 31, 2012 | 5.409M |
September 30, 2012 | 4.172M |
June 30, 2012 | 0.938M |
March 31, 2012 | 2.542M |
December 31, 2011 | 3.219M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.738M
Minimum
Jun 2019
40.18M
Maximum
Dec 2023
19.46M
Average
16.43M
Median
Accounts Receivable (Quarterly) Benchmarks
Fonar Corp | 26.92M |
XWELL Inc | 2.90M |
Applied DNA Sciences Inc | 0.4089M |
Veracyte Inc | 46.66M |
OncoCyte Corp | 0.161M |